What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Dopamine
- Schizophrenia
Her primary scientific interests are in Neuroscience, Dopamine, Psychosis, Schizophrenia and Dopaminergic.
Her Neuroscience research is multidisciplinary, incorporating elements of Clozapine and Antipsychotic.
Alice Egerton interconnects Positron emission tomography and Psychiatry in the investigation of issues within Dopamine.
Her Schizophrenia study incorporates themes from Glutamate receptor, Internal medicine and Endocrinology.
Her study looks at the relationship between Internal medicine and topics such as Addiction, which overlap with Case-control study, Cannabis, Dopamine receptor and Mood.
Alice Egerton has included themes like Pathological, Amphetamine, Impulsivity, Cohort and Dopamine receptor D3 in her Striatum study.
Her most cited work include:
- Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. (241 citations)
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. (187 citations)
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging (186 citations)
What are the main themes of her work throughout her whole career to date?
Alice Egerton spends much of her time researching Psychosis, Neuroscience, Schizophrenia, Internal medicine and Dopamine.
In her research, Anterior cingulate cortex is intimately related to Glutamate receptor, which falls under the overarching field of Psychosis.
Her Schizophrenia research incorporates themes from Hypofrontality, Pharmacology and Phencyclidine.
As part of the same scientific family, Alice Egerton usually focuses on Internal medicine, concentrating on Endocrinology and intersecting with Addiction.
The study of Dopamine is intertwined with the study of Positron emission tomography in a number of ways.
Alice Egerton focuses mostly in the field of Striatum, narrowing it down to topics relating to Amphetamine and, in certain cases, Cohort.
She most often published in these fields:
- Psychosis (68.99%)
- Neuroscience (68.99%)
- Schizophrenia (56.96%)
What were the highlights of her more recent work (between 2019-2021)?
- Internal medicine (54.43%)
- Psychosis (68.99%)
- Schizophrenia (56.96%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Psychosis, Schizophrenia, Antipsychotic and Glutamate receptor.
Her Internal medicine research integrates issues from Endocrinology, Oncology and Clozapine.
Her Psychosis research incorporates elements of Immunotherapy, Dopamine, Neuroscience and Striatal dopamine.
Her Dopamine research includes elements of Positron emission tomography and Neuroimaging.
The various areas that Alice Egerton examines in her Neuroscience study include Glutamatergic and Drug development.
Her Schizophrenia study which covers Resting state fMRI that intersects with Striatum, Oral administration and Frontal gyrus.
Between 2019 and 2021, her most popular works were:
- Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus. (6 citations)
- The potential of 1H-MRS in CNS drug development. (4 citations)
- Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA). (3 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Schizophrenia
- Dopamine
Her scientific interests lie mostly in Schizophrenia, Antipsychotic, Psychosis, Internal medicine and Glutamate receptor.
Alice Egerton combines subjects such as Oral administration, Anterior cingulate cortex and Default mode network with her study of Schizophrenia.
Alice Egerton works mostly in the field of Anterior cingulate cortex, limiting it down to topics relating to Dopamine and, in certain cases, Neuroimaging, as a part of the same area of interest.
Her research combines Clinical research and Psychosis.
As part of her studies on Internal medicine, Alice Egerton often connects relevant areas like Endocrinology.
Her Endocrinology study integrates concerns from other disciplines, such as Cannabinoid and Cannabinoid receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
